Calcitonin Gene-Related Peptide (CGRP) Therapy

Calcitonin gene-related peptide (CGRP) therapy involves the use of monoclonal antibodies to reduce the inflammation and pain associated with chronic migraine headache. It is the most commonly used medication for migraine prophylaxis is erenumab.
Its Effectiveness
Erunamab, as a preventive measure for migraine headaches studied, has proven to help reduce migraine days by 50 percent or more when compared to placebo.
Its Side Effects
Side effects related to CGRP include respiratory infection, injection site pain, gastrointestinal issues, nausea, [6] fatigue, nausea, and more. The effectiveness of CGRP as a way to prevent migraine headaches begins within the first 2 months and gets stronger every time.
Conclusion
Migraine headaches can be so severe that they affect your everyday life. You should visit your doctor if you are experiencing a continuous headache. Your doctor will prescribe to you which preventive treatment option is best for you.
Reference:
[1] https://www.mayoclinic.org/diseases-conditions/depression/in-depth/ssris/art-20044825
[2] https://emedicine.medscape.com/article/1187334-overview
[3] https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/ace-inhibitors/art-20047480
[4] https://www.nhs.uk/conditions/beta-blockers/
[5] https://www.webmd.com/migraines-headaches/triptans-migraines
[6] https://www.webmd.com/digestive-disorders/digestive-diseases-nausea-vomiting











